Home/Filings/4/0001181431-13-019223
4//SEC Filing

Blume Frederick R. 4

Accession 0001181431-13-019223

CIK 0001373707other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 8:14 PM ET

Size

14.7 KB

Accession

0001181431-13-019223

Insider Transaction Report

Form 4
Period: 2013-03-25
Transactions
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-2528,199,1440 total
    Common Stock (972,384 underlying)
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+496,121$3,472,8471,468,505 total
  • Conversion

    Common Stock

    2013-03-25+972,384972,384 total
Enriquez Juan
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-03-25+972,384972,384 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-2528,199,1440 total
    Common Stock (972,384 underlying)
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+496,121$3,472,8471,468,505 total
Transactions
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+496,121$3,472,8471,468,505 total
  • Conversion

    Common Stock

    2013-03-25+972,384972,384 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-2528,199,1440 total
    Common Stock (972,384 underlying)
Transactions
  • Conversion

    Common Stock

    2013-03-25+972,384972,384 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-2528,199,1440 total
    Common Stock (972,384 underlying)
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+496,121$3,472,8471,468,505 total
Transactions
  • Purchase

    Common Stock

    2013-03-25$7.00/sh+496,121$3,472,8471,468,505 total
  • Conversion

    Common Stock

    2013-03-25+972,384972,384 total
  • Conversion

    Series C Convertible Participating Preferred Stock

    2013-03-2528,199,1440 total
    Common Stock (972,384 underlying)
Footnotes (3)
  • [F1]The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
  • [F2]Excel Medical Ventures, LLC is the general partner of Excel Medical Fund, L.P., Frederick R. Blume, Juan Enriquez and Enrico Petrillo are Managing Directors of Excel Medical Ventures, LLC. Excel Medical Ventures, LLC and each of these individuals may be deemed to share voting and dispositive power with respect to all shares held by Excel Medical Fund, L.P. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  • [F3]Not Applicable

Issuer

TETRAPHASE PHARMACEUTICALS INC

CIK 0001373707

Entity typeother

Related Parties

1
  • filerCIK 0001572066

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 8:14 PM ET
Size
14.7 KB